Peer-Reviewed Journal Details
Mandatory Fields
Kilcoyne, M,Sharma, S,McDevitt, N,O'Leary, C,Joshi, L,McMahon, SS
2012
April
Biochemical And Biophysical Research Communications
Neuronal glycosylation differentials in normal, injured and chondroitinase-treated environments
Published
()
Optional Fields
Spinal cord injury Lectins Glycosylation Chondroitin sulphate proteoglycans Neurons In silico analysis SPINAL-CORD-INJURY PROMOTES NEURITE OUTGROWTH FUNCTIONAL RECOVERY NERVOUS-SYSTEM GLIAL SCAR AXON GROWTH EXPRESSION PROTEOGLYCAN REGENERATION GLYCANS
420
616
622
Glycosylation is found ubiquitously throughout the central nervous system (CNS). Chondroitin sulphate proteoglycans (CSPGs) are a group of molecules heavily substituted with glycosaminoglycans (GAGs) and are found in the extracellular matrix (ECM) and cell surfaces. Upon CNS injury, a glial scar is formed, which is inhibitory for axon regeneration. Several CSPGs are up-regulated within the glial scar, including NG2, and these CSPGs are key inhibitory molecules of axonal regeneration. Treatment with chondroitinase ABC (ChABC) can neutralise the inhibitory nature of NG2. A gene expression dataset was mined in silico to verify differentially regulated glycosylation-related genes in neurons after spinal cord injury and identify potential targets for further investigation. To establish the glycosylation differential of neurons that grow in a healthy, inhibitory and ChABC-treated environment, we established an indirect co-culture system where PC12 neurons were grown with primary astrocytes, Neu7 astrocytes (which overexpress NG2) and Neu7 astrocytes treated with ChABC. After 1,4 and 8 days culture, lectin cytochemistry of the neurons was performed using five fluorescently-labelled lectins (ECA MAA, PNA, SNA-I and WFA). Usually alpha-(2,6)-linked sialylation scarcely occurs in the CNS but this motif was observed on the neurons in the injured environment only at day 8. Treatment with ChABC was successful in returning neuronal glycosylation to normal conditions at all timepoints for MAA, PNA and SNA-I staining, and by day 8 in the case of WFA. This study demonstrated neuronal cell surface glycosylation changes in an inhibitory environment and indicated a return to normal glycosylation after treatment with ChABC, which may be promising for identifying potential therapies for neuronal regeneration strategies. (C) 2012 Elsevier Inc. All rights reserved.
DOI 10.1016/j.bbrc.2012.03.047
Grant Details
Publication Themes